Publication | Open Access

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 ® to Suppress Enzalutamide-resistant Prostate Cancer Progression

UrologyMedicinePreclinical StudyProstatic DiseaseOncologyRadiation OncologyEndocrine-related Cancer